Type 2 diabetes and obesity dramatically increase the risk of dementia by up to 60%, accelerating amyloid pathology, cerebrovascular damage, and insulin resistance in the brain, sometimes described as type 3 diabetes [1]
Ozempic is FDA-approved to manage Type 2 Diabetes
PlexusDx's Precision Peptide Genetic Test can provide additional insight into your individual peptide-pathway sensitivities, including how your genetic variants in GIPR, and MC4R pathways may influence your gastrointestinal response to treatment
Semaglutide GLP-1 , which is used to treat Type 2 diabetes by controlling blood sugar levels, has recently been approved by the US FDA for chronic weight management in adults who are overweight or obese
Nutritional needs differ based on body composition, activity level, medical history, and personal preferences